SINOPHARM GROUP (Germany) Analysis

SINOPHARM Stock Analysis Notes

The company last dividend was issued on the 24th of June 2022. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. The company was founded in 2003 and is headquartered in Shanghai, the Peoples Republic of China. SINOPHARM GROUP operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 108370 people. For more information please call the company at 86 21 2305 2666 or visit http://www.sinopharmgroup.com.cn.

SINOPHARM Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SINOPHARM GROUP's market, we take the total number of its shares issued and multiply it by SINOPHARM GROUP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

SINOPHARM Profitablity

The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.

Technical Drivers

As of the 22nd of December, SINOPHARM GROUP has the risk adjusted performance of 0.1541, and Coefficient Of Variation of 538.82. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of SINOPHARM GROUP 15ON, as well as the relationship between them. Please validate SINOPHARM GROUP 15ON information ratio, treynor ratio, value at risk, as well as the relationship between the jensen alpha and maximum drawdown to decide if SINOPHARM GROUP is priced adequately, providing market reflects its prevalent price of 13.1 per share.

SINOPHARM GROUP 15ON Price Movement Analysis

SINOPHARM GROUP Outstanding Bonds

SINOPHARM GROUP Predictive Daily Indicators

SINOPHARM GROUP Forecast Models

SINOPHARM GROUP's time-series forecasting models are one of many SINOPHARM GROUP's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SINOPHARM GROUP's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how SINOPHARM GROUP prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SINOPHARM shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SINOPHARM GROUP. By using and applying SINOPHARM Stock analysis, traders can create a robust methodology for identifying SINOPHARM entry and exit points for their positions.

When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.